Asset Details
Do you wish to reserve the book?
Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data
Do you wish to request the book?
Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data
2015
Overview
Lithium is a widely used and highly effective treatment for mood disorders, but causes poorly characterised adverse effects in kidney and endocrine systems. We aimed to analyse laboratory information system data to determine the incidence of renal, thyroid, and parathyroid dysfunction associated with lithium use.
In a retrospective analysis of laboratory data from Oxford University Hospitals National Health Service Trust (Oxfordshire, UK), we investigated the incidence of renal, thyroid, and parathyroid dysfunction in patients (aged ≥18 years) who had at least two creatinine, thyrotropin, calcium, glycated haemoglobin, or lithium measurements between Oct 1, 1982, and March 31, 2014, compared with controls who had not had lithium measurements taken. We used survival analysis and Cox regression to estimate the hazard ratio (HR) for each event with lithium use, age, sex, and diabetes as covariates.
Adjusting for age, sex, and diabetes, presence of lithium in serum was associated with an increased risk of stage three chronic kidney disease (HR 1·93, 95% CI 1·76–2·12; p<0·0001), hypothyroidism (2·31, 2·05–2·60; p<0·0001), and raised total serum calcium concentration (1·43, 1·21–1·69; p<0·0001), but not with hyperthyroidism (1·22, 0·96–1·55; p=0·1010) or raised adjusted calcium concentration (1·08, 0·88–1·34; p=0·4602). Women were at greater risk of development of renal and thyroid disorders than were men, with younger women at higher risk than older women. The adverse effects occurred early in treatment (HR <1 for length of treatment with lithium). Higher than median lithium concentrations were associated with increased risk of all adverse outcomes.
Lithium treatment is associated with a decline in renal function, hypothyroidism, and hypercalcaemia. Women younger than 60 years and people with lithium concentrations higher than median are at greatest risk. Because lithium remains a treatment of choice for bipolar disorder, patients need baseline measures of renal, thyroid, and parathyroid function and regular long-term monitoring.
None.
Publisher
Elsevier Ltd,Elsevier Limited
Subject
/ Aged
/ Antimanic Agents - adverse effects
/ Bipolar Disorder - drug therapy
/ Bipolar Disorder - epidemiology
/ Calcium
/ Female
/ Humans
/ Kidney Diseases - chemically induced
/ Kidney Diseases - epidemiology
/ Kidneys
/ Lithium
/ Lithium Compounds - adverse effects
/ Male
/ Parathyroid Diseases - chemically induced
/ Parathyroid Diseases - epidemiology
/ Studies
/ Thyroid
/ Thyroid Diseases - chemically induced
